nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—chronic obstructive pulmonary disease	0.528	1	CbGaD
Rifabutin—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0603	0.257	CbGbCtD
Rifabutin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.049	0.209	CbGbCtD
Rifabutin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0331	0.141	CbGbCtD
Rifabutin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0316	0.135	CbGbCtD
Rifabutin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0281	0.12	CbGbCtD
Rifabutin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0165	0.0705	CbGbCtD
Rifabutin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0156	0.0666	CbGbCtD
Rifabutin—HSP90B1—respiratory system—chronic obstructive pulmonary disease	0.00592	0.116	CbGeAlD
Rifabutin—HSP90B1—connective tissue—chronic obstructive pulmonary disease	0.00521	0.102	CbGeAlD
Rifabutin—HSP90B1—bronchus—chronic obstructive pulmonary disease	0.00487	0.0953	CbGeAlD
Rifabutin—HSP90B1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00477	0.0932	CbGeAlD
Rifabutin—HSP90B1—trachea—chronic obstructive pulmonary disease	0.00438	0.0856	CbGeAlD
Rifabutin—HSP90AA1—respiratory system—chronic obstructive pulmonary disease	0.00433	0.0847	CbGeAlD
Rifabutin—HSP90AA1—connective tissue—chronic obstructive pulmonary disease	0.00381	0.0745	CbGeAlD
Rifabutin—HSP90AA1—bronchus—chronic obstructive pulmonary disease	0.00356	0.0697	CbGeAlD
Rifabutin—HSP90AA1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00349	0.0682	CbGeAlD
Rifabutin—HSP90AA1—trachea—chronic obstructive pulmonary disease	0.0032	0.0626	CbGeAlD
Rifabutin—HSP90B1—lung—chronic obstructive pulmonary disease	0.00314	0.0615	CbGeAlD
Rifabutin—Emotional distress—Salbutamol—chronic obstructive pulmonary disease	0.0025	0.0265	CcSEcCtD
Rifabutin—HSP90AA1—lung—chronic obstructive pulmonary disease	0.0023	0.045	CbGeAlD
Rifabutin—Gastrointestinal symptom NOS—Salbutamol—chronic obstructive pulmonary disease	0.00181	0.0191	CcSEcCtD
Rifabutin—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.0014	0.0274	CbGeAlD
Rifabutin—Skin discolouration—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.0132	CcSEcCtD
Rifabutin—Skin discolouration—Formoterol—chronic obstructive pulmonary disease	0.00125	0.0132	CcSEcCtD
Rifabutin—Chest discomfort—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.0127	CcSEcCtD
Rifabutin—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.0124	CcSEcCtD
Rifabutin—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.0116	CcSEcCtD
Rifabutin—Eructation—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.011	CcSEcCtD
Rifabutin—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.0106	CcSEcCtD
Rifabutin—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00095	0.01	CcSEcCtD
Rifabutin—Lymphopenia—Prednisone—chronic obstructive pulmonary disease	0.000866	0.00916	CcSEcCtD
Rifabutin—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.000826	0.00873	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00082	0.00867	CcSEcCtD
Rifabutin—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000769	0.00813	CcSEcCtD
Rifabutin—CYP1A2—lung—chronic obstructive pulmonary disease	0.000743	0.0145	CbGeAlD
Rifabutin—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000721	0.00763	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000721	0.00762	CcSEcCtD
Rifabutin—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000716	0.00757	CcSEcCtD
Rifabutin—Rifampicin—CYP1A2—chronic obstructive pulmonary disease	0.000715	1	CrCbGaD
Rifabutin—Alanine aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.000706	0.00747	CcSEcCtD
Rifabutin—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000697	0.00737	CcSEcCtD
Rifabutin—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.000695	0.00735	CcSEcCtD
Rifabutin—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.000695	0.00735	CcSEcCtD
Rifabutin—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000689	0.00728	CcSEcCtD
Rifabutin—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000688	0.00728	CcSEcCtD
Rifabutin—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000685	0.00725	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000683	0.00723	CcSEcCtD
Rifabutin—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000656	0.00694	CcSEcCtD
Rifabutin—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.000655	0.00692	CcSEcCtD
Rifabutin—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000652	0.0069	CcSEcCtD
Rifabutin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000647	0.00685	CcSEcCtD
Rifabutin—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000633	0.00669	CcSEcCtD
Rifabutin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000626	0.00662	CcSEcCtD
Rifabutin—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000601	0.00636	CcSEcCtD
Rifabutin—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000584	0.00617	CcSEcCtD
Rifabutin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000583	0.00617	CcSEcCtD
Rifabutin—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00058	0.00613	CcSEcCtD
Rifabutin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000568	0.00601	CcSEcCtD
Rifabutin—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00056	0.00593	CcSEcCtD
Rifabutin—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000556	0.00588	CcSEcCtD
Rifabutin—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000556	0.00588	CcSEcCtD
Rifabutin—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000554	0.00586	CcSEcCtD
Rifabutin—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000544	0.00576	CcSEcCtD
Rifabutin—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000542	0.00573	CcSEcCtD
Rifabutin—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000525	0.00555	CcSEcCtD
Rifabutin—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000519	0.00549	CcSEcCtD
Rifabutin—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000519	0.00549	CcSEcCtD
Rifabutin—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000519	0.00549	CcSEcCtD
Rifabutin—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000519	0.00549	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000516	0.00545	CcSEcCtD
Rifabutin—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000511	0.0054	CcSEcCtD
Rifabutin—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000511	0.0054	CcSEcCtD
Rifabutin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000503	0.00532	CcSEcCtD
Rifabutin—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000503	0.00532	CcSEcCtD
Rifabutin—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.0005	0.00529	CcSEcCtD
Rifabutin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000499	0.00528	CcSEcCtD
Rifabutin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000499	0.00527	CcSEcCtD
Rifabutin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000496	0.00524	CcSEcCtD
Rifabutin—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00049	0.00518	CcSEcCtD
Rifabutin—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000484	0.00511	CcSEcCtD
Rifabutin—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.0051	CcSEcCtD
Rifabutin—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000482	0.0051	CcSEcCtD
Rifabutin—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000482	0.0051	CcSEcCtD
Rifabutin—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000477	0.00505	CcSEcCtD
Rifabutin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00047	0.00497	CcSEcCtD
Rifabutin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000468	0.00514	CbGpPWpGaD
Rifabutin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000465	0.00491	CcSEcCtD
Rifabutin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000459	0.00485	CcSEcCtD
Rifabutin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.00484	CcSEcCtD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	0.000457	0.00502	CbGpPWpGaD
Rifabutin—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000455	0.00481	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000454	0.0048	CcSEcCtD
Rifabutin—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00045	0.00476	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.00045	0.00495	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000448	0.00492	CbGpPWpGaD
Rifabutin—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000447	0.00473	CcSEcCtD
Rifabutin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000438	0.00463	CcSEcCtD
Rifabutin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000432	0.00456	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000432	0.00474	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00043	0.00455	CcSEcCtD
Rifabutin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000421	0.00462	CbGpPWpGaD
Rifabutin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00443	CcSEcCtD
Rifabutin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00443	CcSEcCtD
Rifabutin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00443	CcSEcCtD
Rifabutin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00443	CcSEcCtD
Rifabutin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00443	CcSEcCtD
Rifabutin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00443	CcSEcCtD
Rifabutin—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000418	0.00442	CcSEcCtD
Rifabutin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000417	0.00441	CcSEcCtD
Rifabutin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000417	0.00441	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000416	0.0044	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.0044	CcSEcCtD
Rifabutin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00434	CcSEcCtD
Rifabutin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00434	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000408	0.00431	CcSEcCtD
Rifabutin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000407	0.0043	CcSEcCtD
Rifabutin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000396	0.00435	CbGpPWpGaD
Rifabutin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00418	CcSEcCtD
Rifabutin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00418	CcSEcCtD
Rifabutin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00418	CcSEcCtD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—TLR4—chronic obstructive pulmonary disease	0.000395	0.00434	CbGpPWpGaD
Rifabutin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000394	0.00416	CcSEcCtD
Rifabutin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00039	0.00413	CcSEcCtD
Rifabutin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00039	0.00413	CcSEcCtD
Rifabutin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.00411	CcSEcCtD
Rifabutin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000385	0.00407	CcSEcCtD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—chronic obstructive pulmonary disease	0.000385	0.00423	CbGpPWpGaD
Rifabutin—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000383	0.00421	CbGpPWpGaD
Rifabutin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000382	0.00404	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—KL—chronic obstructive pulmonary disease	0.00038	0.00418	CbGpPWpGaD
Rifabutin—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00038	0.00418	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000379	0.00417	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000377	0.00414	CbGpPWpGaD
Rifabutin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000374	0.00395	CcSEcCtD
Rifabutin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000373	0.00395	CcSEcCtD
Rifabutin—HSP90AA1—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000369	0.00405	CbGpPWpGaD
Rifabutin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.0039	CcSEcCtD
Rifabutin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.00388	CcSEcCtD
Rifabutin—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000367	0.00403	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00387	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00387	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000365	0.00402	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000363	0.004	CbGpPWpGaD
Rifabutin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000363	0.00384	CcSEcCtD
Rifabutin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.00384	CcSEcCtD
Rifabutin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00382	CcSEcCtD
Rifabutin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000361	0.00382	CcSEcCtD
Rifabutin—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00036	0.00396	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000359	0.00379	CcSEcCtD
Rifabutin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00379	CcSEcCtD
Rifabutin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00379	CcSEcCtD
Rifabutin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00376	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000354	0.0039	CbGpPWpGaD
Rifabutin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000354	0.00374	CcSEcCtD
Rifabutin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000354	0.00374	CcSEcCtD
Rifabutin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000353	0.00374	CcSEcCtD
Rifabutin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000352	0.00372	CcSEcCtD
Rifabutin—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000352	0.00387	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—KL—chronic obstructive pulmonary disease	0.00035	0.00385	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000348	0.00382	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.00367	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000347	0.00367	CcSEcCtD
Rifabutin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000346	0.00366	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00365	CcSEcCtD
Rifabutin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00363	CcSEcCtD
Rifabutin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00363	CcSEcCtD
Rifabutin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00363	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.000341	0.00375	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000341	0.00375	CbGpPWpGaD
Rifabutin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.0036	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00034	0.00359	CcSEcCtD
Rifabutin—HSP90AA1—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000339	0.00372	CbGpPWpGaD
Rifabutin—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000338	0.00372	CbGpPWpGaD
Rifabutin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00358	CcSEcCtD
Rifabutin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00356	CcSEcCtD
Rifabutin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000336	0.00355	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000334	0.00368	CbGpPWpGaD
Rifabutin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00353	CcSEcCtD
Rifabutin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000333	0.00352	CcSEcCtD
Rifabutin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000333	0.00352	CcSEcCtD
Rifabutin—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000331	0.00364	CbGpPWpGaD
Rifabutin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000331	0.0035	CcSEcCtD
Rifabutin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000331	0.0035	CcSEcCtD
Rifabutin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000331	0.0035	CcSEcCtD
Rifabutin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00349	CcSEcCtD
Rifabutin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.00347	CcSEcCtD
Rifabutin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000329	0.00347	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.00346	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000325	0.00357	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000325	0.00357	CbGpPWpGaD
Rifabutin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00343	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—LY96—chronic obstructive pulmonary disease	0.000324	0.00356	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000322	0.0034	CcSEcCtD
Rifabutin—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000319	0.0035	CbGpPWpGaD
Rifabutin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.00336	CcSEcCtD
Rifabutin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000318	0.00336	CcSEcCtD
Rifabutin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000318	0.00336	CcSEcCtD
Rifabutin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.00336	CcSEcCtD
Rifabutin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000317	0.00335	CcSEcCtD
Rifabutin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000314	0.00332	CcSEcCtD
Rifabutin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000314	0.00332	CcSEcCtD
Rifabutin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000314	0.00332	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000313	0.00344	CbGpPWpGaD
Rifabutin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00331	CcSEcCtD
Rifabutin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000312	0.0033	CcSEcCtD
Rifabutin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000311	0.00329	CcSEcCtD
Rifabutin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000311	0.00329	CcSEcCtD
Rifabutin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.00328	CcSEcCtD
Rifabutin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000306	0.00336	CbGpPWpGaD
Rifabutin—HSP90AA1—LKB1 signaling events—TP53—chronic obstructive pulmonary disease	0.000302	0.00332	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—NOS3—chronic obstructive pulmonary disease	0.000302	0.00332	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.0003	0.0033	CbGpPWpGaD
Rifabutin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.00317	CcSEcCtD
Rifabutin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.00317	CcSEcCtD
Rifabutin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00313	CcSEcCtD
Rifabutin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00313	CcSEcCtD
Rifabutin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000296	0.00313	CcSEcCtD
Rifabutin—HSP90AA1—Integrins in angiogenesis—VEGFA—chronic obstructive pulmonary disease	0.000295	0.00324	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	0.000294	0.00323	CbGpPWpGaD
Rifabutin—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000293	0.00323	CbGpPWpGaD
Rifabutin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00307	CcSEcCtD
Rifabutin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.00305	CcSEcCtD
Rifabutin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000288	0.00305	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—ERBB3—chronic obstructive pulmonary disease	0.000285	0.00314	CbGpPWpGaD
Rifabutin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000284	0.00301	CcSEcCtD
Rifabutin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.00301	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000284	0.003	CcSEcCtD
Rifabutin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000282	0.00299	CcSEcCtD
Rifabutin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00296	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000279	0.00306	CbGpPWpGaD
Rifabutin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000278	0.00294	CcSEcCtD
Rifabutin—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000278	0.00306	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—chronic obstructive pulmonary disease	0.000277	0.00305	CbGpPWpGaD
Rifabutin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00291	CcSEcCtD
Rifabutin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00291	CcSEcCtD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.000274	0.00301	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—MMP9—chronic obstructive pulmonary disease	0.000274	0.00301	CbGpPWpGaD
Rifabutin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00288	CcSEcCtD
Rifabutin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00285	CcSEcCtD
Rifabutin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00284	CcSEcCtD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—CXCL8—chronic obstructive pulmonary disease	0.000268	0.00295	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—NOS3—chronic obstructive pulmonary disease	0.000268	0.00294	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000266	0.00292	CbGpPWpGaD
Rifabutin—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000263	0.00289	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—ERBB3—chronic obstructive pulmonary disease	0.000262	0.00288	CbGpPWpGaD
Rifabutin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00026	0.00275	CcSEcCtD
Rifabutin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00274	CcSEcCtD
Rifabutin—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000256	0.00281	CbGpPWpGaD
Rifabutin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000255	0.0027	CcSEcCtD
Rifabutin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000255	0.0027	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—TGFB1—chronic obstructive pulmonary disease	0.000254	0.0028	CbGpPWpGaD
Rifabutin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00268	CcSEcCtD
Rifabutin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00268	CcSEcCtD
Rifabutin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00268	CcSEcCtD
Rifabutin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00268	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000253	0.00278	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—NOS3—chronic obstructive pulmonary disease	0.000253	0.00278	CbGpPWpGaD
Rifabutin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00266	CcSEcCtD
Rifabutin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00266	CcSEcCtD
Rifabutin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00025	0.00265	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Telomerase—EGFR—chronic obstructive pulmonary disease	0.000249	0.00274	CbGpPWpGaD
Rifabutin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00262	CcSEcCtD
Rifabutin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00262	CcSEcCtD
Rifabutin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00261	CcSEcCtD
Rifabutin—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000246	0.00271	CbGpPWpGaD
Rifabutin—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000246	0.0027	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000243	0.00267	CbGpPWpGaD
Rifabutin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00255	CcSEcCtD
Rifabutin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00253	CcSEcCtD
Rifabutin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00253	CcSEcCtD
Rifabutin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000239	0.00252	CcSEcCtD
Rifabutin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000239	0.00252	CcSEcCtD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—MMP9—chronic obstructive pulmonary disease	0.000238	0.00262	CbGpPWpGaD
Rifabutin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00251	CcSEcCtD
Rifabutin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000234	0.00247	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000233	0.00256	CbGpPWpGaD
Rifabutin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.00244	CcSEcCtD
Rifabutin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00023	0.00253	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	0.000229	0.00252	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000227	0.00249	CbGpPWpGaD
Rifabutin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00238	CcSEcCtD
Rifabutin—HSP90B1—Immune System—TLR2—chronic obstructive pulmonary disease	0.00022	0.00241	CbGpPWpGaD
Rifabutin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000219	0.00231	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000215	0.00236	CbGpPWpGaD
Rifabutin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.00226	CcSEcCtD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—VEGFA—chronic obstructive pulmonary disease	0.000214	0.00235	CbGpPWpGaD
Rifabutin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000208	0.0022	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000208	0.00228	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000207	0.00228	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—KL—chronic obstructive pulmonary disease	0.000206	0.00227	CbGpPWpGaD
Rifabutin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000201	0.00213	CcSEcCtD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—TGFB1—chronic obstructive pulmonary disease	0.0002	0.0022	CbGpPWpGaD
Rifabutin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.00208	CcSEcCtD
Rifabutin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.00207	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000194	0.00213	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000194	0.00213	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—VEGFA—chronic obstructive pulmonary disease	0.000193	0.00212	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—LY96—chronic obstructive pulmonary disease	0.000189	0.00208	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—TNF—chronic obstructive pulmonary disease	0.000187	0.00205	CbGpPWpGaD
Rifabutin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00197	CcSEcCtD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—chronic obstructive pulmonary disease	0.000186	0.00204	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—VEGFA—chronic obstructive pulmonary disease	0.000182	0.002	CbGpPWpGaD
Rifabutin—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000181	0.00199	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	0.00018	0.00198	CbGpPWpGaD
Rifabutin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.0019	CcSEcCtD
Rifabutin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000179	0.00189	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.00017	0.00187	CbGpPWpGaD
Rifabutin—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00017	0.00187	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.00017	0.00187	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000169	0.00186	CbGpPWpGaD
Rifabutin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00178	CcSEcCtD
Rifabutin—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000168	0.00184	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CD8A—chronic obstructive pulmonary disease	0.000166	0.00183	CbGpPWpGaD
Rifabutin—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000166	0.00182	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	0.000165	0.00181	CbGpPWpGaD
Rifabutin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00174	CcSEcCtD
Rifabutin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00174	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00173	CcSEcCtD
Rifabutin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.0017	CcSEcCtD
Rifabutin—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.00175	CbGpPWpGaD
Rifabutin—Shock—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00164	CcSEcCtD
Rifabutin—HSP90B1—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000155	0.0017	CbGpPWpGaD
Rifabutin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00162	CcSEcCtD
Rifabutin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00159	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000151	0.00165	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00015	0.00165	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000149	0.00164	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000147	0.00162	CbGpPWpGaD
Rifabutin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000146	0.00161	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GC—chronic obstructive pulmonary disease	0.000146	0.00161	CbGpPWpGaD
Rifabutin—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000144	0.00159	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00152	CcSEcCtD
Rifabutin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00151	CcSEcCtD
Rifabutin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000142	0.0015	CcSEcCtD
Rifabutin—HSP90AA1—Influenza Infection—TGFB1—chronic obstructive pulmonary disease	0.000142	0.00156	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CRP—chronic obstructive pulmonary disease	0.000141	0.00156	CbGpPWpGaD
Rifabutin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00147	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000138	0.00152	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000138	0.00152	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000138	0.00152	CbGpPWpGaD
Rifabutin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000138	0.00151	CbGpPWpGaD
Rifabutin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00145	CcSEcCtD
Rifabutin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.00145	CcSEcCtD
Rifabutin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.00145	CcSEcCtD
Rifabutin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00144	CcSEcCtD
Rifabutin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.00149	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000136	0.00149	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—TLR4—chronic obstructive pulmonary disease	0.000136	0.00149	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—IL6—chronic obstructive pulmonary disease	0.000133	0.00147	CbGpPWpGaD
Rifabutin—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000131	0.00144	CbGpPWpGaD
Rifabutin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00138	CcSEcCtD
Rifabutin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00137	CcSEcCtD
Rifabutin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.00137	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—IL6—chronic obstructive pulmonary disease	0.000126	0.00138	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000125	0.00138	CbGpPWpGaD
Rifabutin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00132	CcSEcCtD
Rifabutin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00132	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by ERBB2—EGFR—chronic obstructive pulmonary disease	0.000124	0.00136	CbGpPWpGaD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.0013	CbGpPWpGaD
Rifabutin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00123	CcSEcCtD
Rifabutin—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000116	0.00128	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	0.000115	0.00127	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	0.000115	0.00127	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—EGFR—chronic obstructive pulmonary disease	0.000114	0.00125	CbGpPWpGaD
Rifabutin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.0012	CcSEcCtD
Rifabutin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000112	0.00118	CcSEcCtD
Rifabutin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.00123	CbGpPWpGaD
Rifabutin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00114	CcSEcCtD
Rifabutin—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000107	0.00117	CbGpPWpGaD
Rifabutin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.00117	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000105	0.00116	CbGpPWpGaD
Rifabutin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.00115	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000104	0.00114	CbGpPWpGaD
Rifabutin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00106	CcSEcCtD
Rifabutin—Rash—Prednisone—chronic obstructive pulmonary disease	9.97e-05	0.00105	CcSEcCtD
Rifabutin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.00105	CcSEcCtD
Rifabutin—Headache—Prednisone—chronic obstructive pulmonary disease	9.91e-05	0.00105	CcSEcCtD
Rifabutin—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.81e-05	0.00108	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.7e-05	0.00107	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—IL6—chronic obstructive pulmonary disease	9.52e-05	0.00105	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	9.51e-05	0.00105	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CRP—chronic obstructive pulmonary disease	9.48e-05	0.00104	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	9.41e-05	0.00103	CbGpPWpGaD
Rifabutin—Nausea—Prednisone—chronic obstructive pulmonary disease	9.39e-05	0.000993	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	9.36e-05	0.00103	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—TLR4—chronic obstructive pulmonary disease	9.09e-05	0.001	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—IL6—chronic obstructive pulmonary disease	8.87e-05	0.000976	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MMP9—chronic obstructive pulmonary disease	8.85e-05	0.000973	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL1B—chronic obstructive pulmonary disease	8.83e-05	0.000971	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—IL6—chronic obstructive pulmonary disease	8.76e-05	0.000963	CbGpPWpGaD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.61e-05	0.000946	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—TLR2—chronic obstructive pulmonary disease	8.57e-05	0.000943	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KL—chronic obstructive pulmonary disease	8.06e-05	0.000886	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HDAC2—chronic obstructive pulmonary disease	8e-05	0.00088	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.98e-05	0.000877	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	7.97e-05	0.000876	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—VEGFA—chronic obstructive pulmonary disease	7.95e-05	0.000874	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.88e-05	0.000867	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.67e-05	0.000843	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.57e-05	0.000832	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.48e-05	0.000823	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KL—chronic obstructive pulmonary disease	7.44e-05	0.000818	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	7.31e-05	0.000804	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.19e-05	0.000791	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	7.17e-05	0.000789	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	7.17e-05	0.000789	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—EGFR—chronic obstructive pulmonary disease	7.15e-05	0.000786	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	7.08e-05	0.000778	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.9e-05	0.000758	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	6.83e-05	0.000751	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	6.83e-05	0.000751	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.8e-05	0.000748	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—EGFR—chronic obstructive pulmonary disease	6.73e-05	0.000739	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.71e-05	0.000737	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.63e-05	0.000729	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD8A—chronic obstructive pulmonary disease	6.5e-05	0.000714	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	6.48e-05	0.000712	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MMP9—chronic obstructive pulmonary disease	6.32e-05	0.000695	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.29e-05	0.000692	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.25e-05	0.000687	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.21e-05	0.000682	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.16e-05	0.000678	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERBB3—chronic obstructive pulmonary disease	6.04e-05	0.000664	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.92e-05	0.000651	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.84e-05	0.000642	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	5.67e-05	0.000624	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.61e-05	0.000616	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERBB3—chronic obstructive pulmonary disease	5.58e-05	0.000613	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.53e-05	0.000608	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CRP—chronic obstructive pulmonary disease	5.52e-05	0.000607	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—IL6—chronic obstructive pulmonary disease	5.5e-05	0.000604	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.45e-05	0.000599	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—TLR4—chronic obstructive pulmonary disease	5.3e-05	0.000582	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.25e-05	0.000577	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.21e-05	0.000573	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	5.21e-05	0.000572	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.18e-05	0.000569	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL6—chronic obstructive pulmonary disease	5.17e-05	0.000568	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.1e-05	0.000561	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.08e-05	0.000559	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TNF—chronic obstructive pulmonary disease	4.86e-05	0.000534	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.82e-05	0.00053	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.82e-05	0.00053	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.81e-05	0.000529	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	4.77e-05	0.000524	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.76e-05	0.000523	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOS2—chronic obstructive pulmonary disease	4.65e-05	0.000511	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.57e-05	0.000503	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.51e-05	0.000496	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	4.51e-05	0.000496	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.3e-05	0.000473	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—chronic obstructive pulmonary disease	3.97e-05	0.000436	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—IL6—chronic obstructive pulmonary disease	3.92e-05	0.000431	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SERPINE1—chronic obstructive pulmonary disease	3.92e-05	0.000431	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.91e-05	0.000429	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.76e-05	0.000413	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOS3—chronic obstructive pulmonary disease	3.74e-05	0.000411	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.68e-05	0.000404	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.5e-05	0.000384	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6—chronic obstructive pulmonary disease	3.46e-05	0.000381	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL1B—chronic obstructive pulmonary disease	3.45e-05	0.000379	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.4e-05	0.000374	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ALB—chronic obstructive pulmonary disease	3.27e-05	0.00036	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.16e-05	0.000347	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.13e-05	0.000344	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	3.07e-05	0.000338	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.85e-05	0.000314	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.74e-05	0.000302	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGFR—chronic obstructive pulmonary disease	2.63e-05	0.000289	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.62e-05	0.000288	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TGFB1—chronic obstructive pulmonary disease	2.47e-05	0.000272	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.44e-05	0.000268	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—EGFR—chronic obstructive pulmonary disease	2.42e-05	0.000267	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.37e-05	0.000261	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.32e-05	0.000255	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.27e-05	0.00025	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.2e-05	0.000242	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.1e-05	0.000231	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6—chronic obstructive pulmonary disease	2.02e-05	0.000222	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.89e-05	0.000207	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6—chronic obstructive pulmonary disease	1.86e-05	0.000205	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.73e-05	0.00019	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.7e-05	0.000187	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.68e-05	0.000184	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.66e-05	0.000182	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.55e-05	0.00017	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.51e-05	0.000166	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.43e-05	0.000157	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.3e-05	0.000143	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.29e-05	0.000142	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.28e-05	0.000141	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.17e-05	0.000128	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.16e-05	0.000128	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.15e-05	0.000126	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.08e-05	0.000118	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.07e-05	0.000117	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.01e-05	0.000111	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.97e-06	9.87e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.85e-06	9.73e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.25e-06	9.07e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.82e-06	8.6e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	6.89e-06	7.57e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.59e-06	7.24e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.31e-06	5.84e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.08e-06	5.59e-05	CbGpPWpGaD
